InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,222.68
(
0.16%
)
US TECH 100
17,650.00
(
0.05%
)
Dow Jones
39,512.84
(
0.32%
)
Brent Oil
82.59
(
0.00%
)
Bitcoin
60,809.18
(
0.02%
)
Post# of 307
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

harr449

Send PM Follow Ignore
Followers 87
Posts 32828
Boards Moderated 1
Alias Born 12/19/2004

harr449

Re: None

Tuesday, 03/06/2012 5:03:16 PM

Tuesday, March 06, 2012 5:03:16 PM

Post# of 307
ILNS Intellect Neurosciences Receives Notice of Allowance from United States Patent and Trademark Office for its ANTISENILIN® Alzheimer's Disease Immunotherapy Technology Platform

USPTO allows claims directed to methods of treating Alzheimer's disease using therapeutic antibodies that recognize the free C-terminus of Beta Amyloid 1-40

http://finance.yahoo.com/news/intellect-neurosciences-receives-notice-allowance-133000163.html




Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up